Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bc0646b5d74907cbc61c61a8ce8857f0e> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bc0646b5d74907cbc61c61a8ce8857f0e NCIT_P378 "NCI" @default.
- Bc0646b5d74907cbc61c61a8ce8857f0e type Axiom @default.
- Bc0646b5d74907cbc61c61a8ce8857f0e annotatedProperty IAO_0000115 @default.
- Bc0646b5d74907cbc61c61a8ce8857f0e annotatedSource NCIT_C161925 @default.
- Bc0646b5d74907cbc61c61a8ce8857f0e annotatedTarget "A chemotherapy regimen consisting of cytarabine (Ara-C), topotecan, and gemtuzumab ozogamicin that may be used as induction therapy in myelodysplastic syndrome (MDS) and for the treatment of secondary or relapsed acute myeloid leukemia (AML)." @default.